These results demonstrate the potential benefits of heterologous boosting (mix-and-match). The article describing these results have been posted on medRxiv
SPARC will pay Biomodifying a percentage of payments received for sublicenses of the licensed IP
Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively
Union Minister Dr Jitendra Singh said a large number of Covid-19 bio-repositories and samples were made available to academia and industry
A single-cell analysis solution that revolutionizes efficiency in drug discovery research by automating the collection of specific cells and intracellular components
The U.S. FDA advisory committee voted 13-10 in favour of the oral antiviral medicine
She replaces Victoria Tabiner, who is stepping down after 10 years at Sygnature
The country’s top heart transplant surgeon Dr. K.R Balakrishnan to be leading the programme for Jaslok
TIB Molbiol excels in ultra-rapid assay development for emerging infectious diseases, strongly demonstrated during the Covid-19 pandemic
Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications
Subscribe To Our Newsletter & Stay Updated
